MetaCap

Zimmer Biomet Holdings Inc. (ZBH)

NYSE: ZBHHealth CareIndustrial SpecialtiesUSD

101.10-0.37 (-0.36%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ZBH stock chart

Technical analysis

Key statistics

All statistics
Market cap
$19.13B
Dividend yield
0.95% ($0.96)
Ex-dividend date
Sep 30, 2026
52-week range
79.12 – 112.55
Day range
100.82 – 103.84
Volume / Avg
2.96M / 2.15M
Beta
—

52-week range

$79.12$112.55

ZBH stock today

Zimmer Biomet (ZBH) closed at $101.10 on Nov 20, down 0.36% (-$0.37), versus the S&P 500's 3.70% decline. At this level, ZBH sits in the middle of its 52-week range of $79.12 to $112.55: 10.2% below the high, set on Nov 4, 2026 and 27.8% above the low. ZBH is up 12.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 9.7%.

At 25.5x trailing earnings, Zimmer Biomet trades above the peer-group median of 22.2x. Its forward P/E of 11.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Zimmer Biomet pays an annual dividend of $0.96 per share, a 0.95% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Zimmer Biomet

Company profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest.

Industry
Industrial Specialties
CEO
Mr. Ivan Tornos
Headquarters
Warsaw, IN
Employees
17,000

Financial highlights

Full financials

In fiscal 2025, Zimmer Biomet generated $8.23 billion in revenue, up 7.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $705.1 million (-22.0% year over year), for a net margin of 8.6% versus a median of 5.9% in the prior 5 years. Gross margin was 69.7% (down from 71.5%) and operating margin 13.3%.

Zimmer Biomet annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$8.23B$7.68B$7.39B$6.94B$6.83B
Growth+7.20%+3.85%+6.55%+1.65%+11.42%
Net income$705.10M$903.80M$1.02B$231.40M$401.60M
EPS (diluted)$3.55$4.43$4.88$1.10$1.91

Analyst forecast

Forecast

Consensus (27 analysts)

buy

Avg. price target

$117.48+16.20%

  • Strong buy 2
  • Buy 7
  • Hold 18
  • Sell 0
  • Strong sell 0

Target range

Low $98.00High $140.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$1.00 vs $1.89
Surprise
-47.09%

Dividends

Dividend history
Annual dividend
$0.96
Last payment
$0.24
Ex-dividend date
Sep 30, 2026

ZBH news

All ZBH news

Zimmer Biomet peers

Health Care sector
ZBH peer companies
CompanyPrice% ChgMarket capCompare
MASMasco Corporation82.60-0.23%$15.92Bvs ZBH
STESTERIS plc (Ireland)255.76+0.39%$24.84Bvs ZBH
SNNSmith & Nephew SNATS Inc.29.830.00%$12.47Bvs ZBH
ALGNAlign Technology Inc.155.17-2.82%$10.94Bvs ZBH
AITApplied Industrial Technologies Inc.274.99-4.65%$10.04Bvs ZBH
POOLPool Corporation208.23-0.70%$7.44Bvs ZBH
MSAMSA Safety Incorporated170.03-3.52%$6.55Bvs ZBH
DOOBRP Inc. Common Subordinate Voting Shares61.90-1.56%$4.40Bvs ZBH

Indexes, lists and sector

Zimmer Biomet stock FAQ

What is Zimmer Biomet's stock price today?

ZBH last traded at $101.10 as of Nov 20, 4:00 PM EST, down 0.36% on the day. Prices are delayed at least 15 minutes.

Does Zimmer Biomet pay a dividend?

Yes. Zimmer Biomet pays $0.96 per share annually, a 0.95% yield. The most recent dividend of $0.24 had an ex-dividend date of Sep 30, 2026.

What is ZBH's P/E ratio?

ZBH trades at a trailing P/E ratio of 25.53 and a forward P/E of 11.27, compared with a median of 22.2 for its closest peers.

Is Zimmer Biomet in the S&P 500?

Yes. Zimmer Biomet (ZBH) is a constituent of the S&P 500 index.

Who is Zimmer Biomet's CEO?

Mr. Ivan Tornos is the chief executive officer of Zimmer Biomet Holdings Inc., which has about 17,000 employees.

Has ZBH ever split its stock?

Yes. The most recent ZBH stock split was a 103-for-100 split on Mar 1, 2022.

What is the ZBH 52-week high?

The 52-week high for ZBH is $112.55 and the 52-week low is $79.12. The stock is currently 10.2% below its high.

Compare ZBH